Darren M. Kozik
Thanks, Paul. As seen on Slide 3, Enerpac's revenue increased 6% on a reported basis to $159 million in the third quarter of 2025. On an organic basis, adjusting for foreign exchange and the acquisition of DTA, we grew 2%. At our IT&S business, revenue increased 1.5% organically year-over-year. Both our product and service business grew this quarter with 1% growth in product sales and 3% growth in services. We continue to implement Enerpac Commercial Excellence, or ECX, across our portfolio. We believe this will add rigor and discipline to our sales process and funnel management, which we believe will contribute to our above-market growth. Cortland Biomedical reported in our Other segment posted growth of 19% with good performance of existing products and market reception to new product launches, in particular, we enjoyed strength in sales to customers in diagnostics, bioprocessing and robotic surgery. Cortland continues to partner with customers to develop innovative solutions with several quotes and prototype orders in the works from existing and new customers. Turning to Slide 4, which shows our growth by geography. We delivered another strong quarter in the Americas with high single-digit organic growth. The growth was driven by demand for our standard products and services. While there has been a bit of softness in the rail and general industrial manufacturing sectors, we've seen particular strength in aerospace, infrastructure and service for the nuclear industry. We believe these industries align with Enerpac's product portfolio and service offerings. In the APAC region, we continue to generate solid performance as it enjoyed mid-single-digit growth in the third quarter. A particular strength in the quarter was our heavy lifting technology for HLC business. From a vertical market perspective, we are benefiting from major rail projects and maintenance needs in Thailand, Japan and the Philippines. We also see growth opportunities in solar farms in Vietnam and wind projects in Japan. At the same time, there are some more challenged end markets, including the steel industry in South Korea and refining and petrochemicals in China. In the EMEA region, we posted a high single-digit decline organically, driven by a decline in our HLT business, which had a strong performance in the year ago period. And as we said, it tends to be lumpy. From a vertical market perspective, we are seeing strength from the infrastructure market and are benefiting from higher defense budgets, spending in the oil and gas sector and ongoing wind projects. However, we are seeing some softness in our service revenue in Europe and the effect of an overall economic slowdown in Western Europe. Turning to Slide 5. Gross profit margin declined 140 basis points year-over-year to 50.4%. This decline was attributable to our service project mix and the inclusion of DTA, partially offset by higher margins at Cortland Biomedical. While we've continued to experience pressure on service margins from the project mix on a year-over-year basis, we did enjoy sequential improvement based on actions taken earlier this year to focus on migrating to a more differentiated and value-added service opportunities. We've also taken specific actions, including investing in equipment to support high-margin service lines, we're refining our fixed cost base to ensure each site is generating appropriate returns and changing our business model in certain countries, all designed to improve service business margins. On the selling, general and administrative line, adjusting for the restructuring charge and M&A expense, adjusted SG&A improved 160 basis points year-over-year to 25.5% of sales. In light of the current soft market conditions, we recorded a restructuring charge of $5.9 million in the quarter, of which approximately 3/4 is people-related severance to further rightsize our cost structure. Additionally, these restructuring actions are another step towards increasing the efficiency of our SG&A spend as we continue to standardize and automate processes. The remainder of the restructuring charge is a noncash lease impairment associated with our headquarters relocation. We will continue to watch SG&A spending closely in the current environment. As a result, adjusted EBITDA increased 3.4% for the third quarter. The margin declined 50 basis points year-over-year to 25.9% due to the mix of service projects and the inclusion of DTA. Our core IT&S product portfolio margin remains strong in the current environment pointing to the resiliency of our brand. Adjusted earnings per share increased 9% to $0.51, driven by higher earnings, a lower effective tax rate and reduced share count. For the full year fiscal 2025, our earnings guidance remains the same with net sales of $610 million to $625 million, representing total revenue growth of 3% to 6% and organic growth of 0% to 2%. Adjusted EBITDA is expected to be in the $150 million to $160 million range. However, based on year-to-date results and current macroeconomic and geopolitical conditions, we anticipate delivering towards the lower half of the range. Turning to the balance sheet, shown on Slide 7, Enerpac's position remains extremely strong. Net debt was $50 million at quarter end, resulting in a net debt to adjusted EBITDA ratio of 0.4. Total liquidity, including availability under revolver and cash on hand was $539 million. Through the first 3 quarters of fiscal 2025, cash flow from operations was $56 million compared with $37 million in the year ago period. Free cash flow of $40 million increased 24% despite $11 million in incremental capital spending, primarily associated with the headquarters relocation. In addition to our headquarters, we continue to invest in automated manufacturing capabilities to improve the efficiency and drive additional productivity. For the full year, we are maintaining our free cash flow guidance at $85 million to $95 million. In the third quarter, the company repurchased approximately 330,000 shares of common stock totaling $14 million. As we continue to generate cash, coupled with our current leverage, we have ample capacity to deploy capital for our disciplined M&A strategy as well as internal investments and continued opportunistic share repurchases. Turning to Slide 8. We understand that the impact of the U.S. tariff policy and associated uncertainty it has created is top of mind for investors. While the situation is fluid, we believe that Enerpac is well positioned to manage the impact given our global footprint and diverse supply base. The majority of our imported finished goods and components come from 4 countries: Netherlands, where we manufacture our HLT products, China, the U.K. and Spain. The Netherlands and China make up the bulk of our U.S. imports that are subject to duties. We import a total of approximately $50 million in finished good and components into the U.S. that are subject to tariffs. Under the current tariff framework, we estimate an annualized tariff impact of $18 million, which represents an incremental $12 million relative to the total tariffs paid in fiscal 2024. In addition to these quantifiable direct impacts, we anticipate additional cost pressure on our U.S.-based suppliers who are importing components and raw materials. We believe we'll be able to mitigate the majority of the impact. As noted on the second quarter earnings call, we implemented a low to mid-single-digit price increase at the end of March. And in May, we implemented a low single-digit surcharge in the U.S. to offset the announced tariffs. These pricing actions have been understood and accepted by our customers. Additionally, given the global nature of our business, we have the flexibility to secure alternative suppliers. We expect these actions to support our goal of remaining at least price/cost neutral. What we cannot calculate at this juncture is any impact of economic uncertainty and potentially slower growth on the revenue line. That said, we will continue to pursue our strategy focused on driving profitable growth and outperforming the industrial market. We will also continue to carefully manage expenses as appropriate to align our cost structure with market conditions in support of long- term success. With that, let me turn it back to Paul.